statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	679
IT - Italia	357
CN - Cina	215
SG - Singapore	215
VN - Vietnam	193
DE - Germania	61
FR - Francia	49
GB - Regno Unito	45
SE - Svezia	39
NL - Olanda	36
HK - Hong Kong	34
IN - India	34
KR - Corea	31
BD - Bangladesh	28
BG - Bulgaria	26
SC - Seychelles	23
BR - Brasile	21
FI - Finlandia	21
CI - Costa d'Avorio	16
CA - Canada	15
IE - Irlanda	15
RU - Federazione Russa	14
ZA - Sudafrica	14
CH - Svizzera	12
JP - Giappone	12
TG - Togo	11
ID - Indonesia	10
AR - Argentina	9
JO - Giordania	8
AT - Austria	7
ES - Italia	7
MX - Messico	7
PH - Filippine	6
BE - Belgio	5
IQ - Iraq	5
LT - Lituania	3
PK - Pakistan	3
PL - Polonia	3
PT - Portogallo	3
AZ - Azerbaigian	2
CZ - Repubblica Ceca	2
EE - Estonia	2
HN - Honduras	2
IL - Israele	2
MA - Marocco	2
NG - Nigeria	2
SK - Slovacchia (Repubblica Slovacca)	2
TH - Thailandia	2
TW - Taiwan	2
UA - Ucraina	2
AL - Albania	1
AM - Armenia	1
AU - Australia	1
BO - Bolivia	1
CL - Cile	1
CO - Colombia	1
CY - Cipro	1
DK - Danimarca	1
EC - Ecuador	1
EG - Egitto	1
HR - Croazia	1
KZ - Kazakistan	1
LB - Libano	1
MD - Moldavia	1
NP - Nepal	1
RO - Romania	1
RS - Serbia	1
SA - Arabia Saudita	1
TR - Turchia	1
UG - Uganda	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	2.336

Nome	#
Long term breeding of the Lmna G609G progeric mouse: Characterization of homozygous and heterozygous models	297
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors	253
Decrease in Heparan Sulphate Binding in Tropism-Retargeted Oncolytic Herpes Simplex Virus (ReHV) Delays Blood Clearance and Improves Systemic Anticancer Efficacy	242
Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice	212
αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion	211
Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers	189
Towards a precision medicine approach and in situ vaccination against prostate cancer by psma-retargeted ohsv	185
Interleukin-6 neutralization ameliorates symptoms in prematurely aged mice	175
Immunocompetent C57BL/6 mouse, engineered to be tolerant to the human HER2 receptor, as a model for the study of retargeted fully-virulent oncolytic Herpes Virus (HSV)	172
Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV	165
Immunotherapeutic efficacy of retargeted ohsvs designed for propagation in an ad hoc cell line	159
An antibiotic derivative as a new potential tool in the prevention of hemolytic uremic syndrome	140
Totale	2.400

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	12	0	0	0	0	0	0	0	0	0	0	0	12
2021/2022	187	6	0	5	4	8	19	4	17	17	28	56	23
2022/2023	237	21	17	8	29	17	14	7	9	46	20	21	28
2023/2024	145	6	15	17	18	13	28	9	20	4	5	6	4
2024/2025	447	26	51	52	28	26	33	47	20	5	55	54	50
2025/2026	1.173	95	118	132	110	92	48	96	32	213	102	53	82
Totale													2.400

CRIS Current Research Information System